Adult psychiatric outpatients with attention-deficit/hyperactivity disorder (ADHD) had higher levels of uncertainty intolerance compared with outpatients without ADHD, according to a poster presented at the virtual 2021 APA Meeting.
While there is a known link between prenatal alcohol and tobacco use with ADHD and autism spectrum disorder (ASD), there is no known association between substance use during lactation and increased ADHD and ASD.
Vladimir Maletic, MD, MS, and Greg Mattingly, MD, discuss recent research on the use of medications for attention-deficit/hyperactivity disorder in patients with comorbidities such as anxiety disorders, mood disorders, and tic disorders.
Community attitudes towards individuals with attention-deficit/hyperactivity disorder (ADHD) are “generally negative,” but targeted mental health literacy efforts aimed at providing information and education could improve those attitudes.
The digital therapeutic treatment AKL-T01 significantly improved attention-deficit/hyperactivity disorder (ADHD) symptoms and related impairments in both children who used, and did not use, stimulant medication.
The US Food and Drug Administration has classified the resubmission of the New Drug Application for SPN-812 as Class I, setting early April as the Prescription Drug User Fee Act target action date, Supernus Pharmaceuticals, Inc. announced.
Consistent participation in extracurricular sports during the elementary school years predicted fewer attention-deficit/hyperactivity disorder (ADHD) symptoms at age 12 in girls—but not in boys, according to a study in Preventive Medicine.
Children with attention-deficit/hyperactivity disorder (ADHD) who are African American appear to have key genetic differences from those who are Caucasian, according to a study published in Scientific Reports.
AR19, an investigational stimulant for attention-deficit/hyperactivity disorder (ADHD), improved symptoms in adults with ADHD in a Phase 3 trial, according to a poster presented at Psych Congress 2020.